$617 Million is the total value of Ghost Tree Capital, LLC's 88 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 106.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SERIES TRUSTput | $49,718,000 | +129.8% | 750,000 | +87.5% | 8.06% | +29.1% |
| IBB | New | ISHARES TRput | $28,946,000 | – | 100,000 | +100.0% | 4.69% | – |
| IWM | Sell | ISHARES TRput | $27,947,000 | -30.6% | 225,000 | -35.7% | 4.53% | -61.0% |
| SRPT | Buy | SAREPTA THERAPEUTICS INCput | $24,564,000 | +329.4% | 400,000 | +33.3% | 3.98% | +141.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INCcall | $21,494,000 | +1027.1% | 350,000 | +250.0% | 3.49% | +532.7% |
| BIIB | New | BIOGEN INCcall | $20,347,000 | – | 65,000 | +100.0% | 3.30% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $18,025,000 | +192.0% | 500,000 | +11.1% | 2.92% | +63.9% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $16,253,000 | – | 125,000 | +100.0% | 2.64% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $14,705,000 | +39.9% | 120,000 | +33.3% | 2.38% | -21.4% |
| NUVA | Buy | NUVASIVE INC | $13,999,000 | +56.3% | 210,000 | +40.0% | 2.27% | -12.3% |
| GWPH | New | GW PHARMACEUTICALS PLCcall | $13,273,000 | – | 100,000 | +100.0% | 2.15% | – |
| ABT | New | ABBOTT LABS | $12,687,000 | – | 300,000 | +100.0% | 2.06% | – |
| AERI | New | AERIE PHARMACEUTICALS INCcall | $11,322,000 | – | 300,000 | +100.0% | 1.84% | – |
| SPNC | Buy | SPECTRANETICS CORP | $10,914,000 | +55.6% | 435,000 | +16.0% | 1.77% | -12.6% |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $10,784,000 | – | 200,000 | +100.0% | 1.75% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORPcall | $10,710,000 | +30.9% | 450,000 | +28.6% | 1.74% | -26.5% |
| CELG | Buy | CELGENE CORP | $10,453,000 | +323.9% | 100,000 | +300.0% | 1.70% | +138.1% |
| WMGI | Buy | WRIGHT MED GROUP N V | $10,425,000 | +140.0% | 425,000 | +70.0% | 1.69% | +34.8% |
| EW | EDWARDS LIFESCIENCES CORP | $10,248,000 | +20.9% | 85,000 | 0.0% | 1.66% | -32.1% | |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $10,058,000 | – | 150,000 | +100.0% | 1.63% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $9,520,000 | +25.3% | 400,000 | +23.1% | 1.54% | -29.6% |
| MRK | New | MERCK & CO INCcall | $9,362,000 | – | 150,000 | +100.0% | 1.52% | – |
| OPHT | New | OPHTHOTECH CORPcall | $9,226,000 | – | 200,000 | +100.0% | 1.50% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $9,212,000 | +141.5% | 150,000 | -25.0% | 1.49% | +35.7% |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $9,083,000 | – | 250,000 | +100.0% | 1.47% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $8,059,000 | – | 175,000 | +100.0% | 1.31% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $7,938,000 | +64.4% | 1,800,000 | +5.9% | 1.29% | -7.7% |
| CELG | New | CELGENE CORPcall | $7,840,000 | – | 75,000 | +100.0% | 1.27% | – |
| CYNO | New | CYNOSURE INCcl a | $7,641,000 | – | 150,000 | +100.0% | 1.24% | – |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $7,493,000 | +137.9% | 375,000 | +50.0% | 1.22% | +33.5% |
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $7,130,000 | +89.7% | 575,000 | +64.3% | 1.16% | +6.4% |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $6,790,000 | +19.8% | 825,000 | +17.9% | 1.10% | -32.7% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $6,720,000 | – | 750,000 | +100.0% | 1.09% | – |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $6,653,000 | – | 250,000 | +100.0% | 1.08% | – |
| IMMU | Buy | IMMUNOMEDICS INC | $6,500,000 | +180.2% | 2,000,000 | +100.0% | 1.05% | +57.3% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $6,362,000 | – | 200,000 | +100.0% | 1.03% | – |
| NVRO | Sell | NEVRO CORP | $6,263,000 | +6.1% | 60,000 | -25.0% | 1.02% | -40.4% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $5,600,000 | -24.2% | 400,000 | -30.4% | 0.91% | -57.4% |
| RTRX | New | RETROPHIN INC | $5,595,000 | – | 250,000 | +100.0% | 0.91% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $5,551,000 | -35.1% | 60,000 | -45.5% | 0.90% | -63.6% |
| IONS | New | IONIS PHARMACEUTICALS INCcall | $5,496,000 | – | 150,000 | +100.0% | 0.89% | – |
| QGEN | New | QIAGEN NV | $5,488,000 | – | 200,000 | +100.0% | 0.89% | – |
| HZNP | Buy | HORIZON PHARMA PLCcall | $5,439,000 | +65.1% | 300,000 | +50.0% | 0.88% | -7.3% |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $5,220,000 | -37.0% | 250,000 | -23.1% | 0.85% | -64.6% |
| AERI | New | AERIE PHARMACEUTICALS INC | $4,718,000 | – | 125,000 | +100.0% | 0.76% | – |
| BIIB | Sell | BIOGEN INC | $4,695,000 | -35.3% | 15,000 | -50.0% | 0.76% | -63.7% |
| ACRS | New | ACLARIS THERAPEUTICS INC | $4,482,000 | – | 175,000 | +100.0% | 0.73% | – |
| ENTL | Buy | ENTELLUS MED INC | $4,436,000 | +102.4% | 200,000 | +66.7% | 0.72% | +13.6% |
| PTHN | New | PATHEON N V | $4,298,000 | – | 275,700 | +100.0% | 0.70% | – |
| HZNP | Sell | HORIZON PHARMA PLC | $4,079,000 | -0.9% | 225,000 | -10.0% | 0.66% | -44.3% |
| BLUE | Sell | BLUEBIRD BIO INC | $4,067,000 | -44.7% | 60,000 | -64.7% | 0.66% | -68.9% |
| ELGX | Sell | ENDOLOGIX INC | $3,840,000 | -23.0% | 300,000 | -25.0% | 0.62% | -56.7% |
| ZGNX | New | ZOGENIX INC | $3,715,000 | – | 325,000 | +100.0% | 0.60% | – |
| KITE | New | KITE PHARMA INCcall | $3,631,000 | – | 65,000 | +100.0% | 0.59% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $3,340,000 | – | 250,000 | +100.0% | 0.54% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $3,181,000 | – | 20,000 | +100.0% | 0.52% | – |
| KTWO | Sell | K2M GROUP HLDGS INC | $3,112,000 | -42.7% | 175,000 | -50.0% | 0.50% | -67.8% |
| CYH | New | COMMUNITY HEALTH SYS INC NEWcall | $2,885,000 | – | 250,000 | +100.0% | 0.47% | – |
| EXAS | New | EXACT SCIENCES CORP | $2,786,000 | – | 150,000 | +100.0% | 0.45% | – |
| VCYT | Buy | VERACYTE INC | $2,770,000 | +61.1% | 364,000 | +6.5% | 0.45% | -9.5% |
| AKBA | New | AKEBIA THERAPEUTICS INC | $2,715,000 | – | 300,000 | +100.0% | 0.44% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $2,633,000 | – | 325,000 | +100.0% | 0.43% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $2,569,000 | +44.0% | 700,000 | -12.5% | 0.42% | -19.0% |
| New | NEURODERM LTD | $2,422,000 | – | 131,000 | +100.0% | 0.39% | – | |
| GHDX | Sell | GENOMIC HEALTH INC | $2,169,000 | -58.1% | 75,000 | -62.5% | 0.35% | -76.5% |
| DVAX | New | DYNAVAX TECHNOLOGIES CORPcall | $2,098,000 | – | 200,000 | +100.0% | 0.34% | – |
| OPHT | New | OPHTHOTECH CORPput | $2,011,000 | – | 43,600 | +100.0% | 0.33% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $1,847,000 | – | 111,000 | +100.0% | 0.30% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $1,818,000 | +343.4% | 275,000 | +266.7% | 0.30% | +150.0% |
| CNMD | Sell | CONMED CORP | $1,803,000 | -78.4% | 45,000 | -74.3% | 0.29% | -87.9% |
| TSRO | Sell | TESARO INC | $1,704,000 | -59.5% | 17,000 | -66.0% | 0.28% | -77.3% |
| TXMD | New | THERAPEUTICSMD INC | $1,703,000 | – | 250,000 | +100.0% | 0.28% | – |
| ITEK | New | INOTEK PHARMACEUTICALS CORP | $1,612,000 | – | 170,000 | +100.0% | 0.26% | – |
| ADHD | Buy | ALCOBRA LTD | $1,606,000 | +19.2% | 650,000 | +116.7% | 0.26% | -33.2% |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $1,463,000 | – | 157,962 | +100.0% | 0.24% | – |
| ARIA | New | ARIAD PHARMACEUTICALS INCput | $1,369,000 | – | 100,000 | +100.0% | 0.22% | – |
| CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $1,358,000 | +51.4% | 200,000 | -33.3% | 0.22% | -15.1% |
| TNDM | TANDEM DIABETES CARE INC | $1,149,000 | +1.6% | 150,000 | 0.0% | 0.19% | -43.1% | |
| AVXS | New | AVEXIS INC | $1,094,000 | – | 26,536 | +100.0% | 0.18% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $916,000 | – | 25,000 | +100.0% | 0.15% | – |
| NVAX | New | NOVAVAX INCcall | $832,000 | – | 400,000 | +100.0% | 0.14% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $524,000 | – | 16,000 | +100.0% | 0.08% | – |
| QTNT | New | QUOTIENT LTD | $469,000 | – | 60,000 | +100.0% | 0.08% | – |
| NVAX | New | NOVAVAX INCput | $416,000 | – | 200,000 | +100.0% | 0.07% | – |
| AKTX | AKARI THERAPEUTICS PLCsponsored adr | $397,000 | -36.9% | 46,622 | 0.0% | 0.06% | -64.8% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $321,000 | +32.1% | 50,000 | 0.0% | 0.05% | -25.7% | |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $303,000 | +260.7% | 55,000 | +150.0% | 0.05% | +104.2% |
| ITEK | New | INOTEK PHARMACEUTICALS CORPcall | $196,000 | – | 20,700 | +100.0% | 0.03% | – |
| OCRX | Exit | OCERA THERAPEUTICS INC | $0 | – | -35,801 | -100.0% | -0.02% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.13% | – |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -200,000 | -100.0% | -0.13% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -10,500 | -100.0% | -0.18% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -20,000 | -100.0% | -0.21% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -15,000 | -100.0% | -0.36% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -100,000 | -100.0% | -0.38% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -150,000 | -100.0% | -0.39% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -12,700 | -100.0% | -0.52% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -600,000 | -100.0% | -0.93% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -1.17% | – |
| TSRO | Exit | TESARO INCcall | $0 | – | -50,000 | -100.0% | -1.21% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -150,000 | -100.0% | -1.30% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -120,000 | -100.0% | -1.34% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INcall | $0 | – | -35,000 | -100.0% | -1.44% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -125,000 | -100.0% | -1.64% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCput | $0 | – | -500,000 | -100.0% | -1.98% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -100,000 | -100.0% | -2.51% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -215,000 | -100.0% | -3.17% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCput | $0 | – | -130,000 | -100.0% | -3.44% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -100,000 | -100.0% | -6.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.